In this study, we provide evidence that the IDO/TDO-downstream AHR activation represents a common feature of cancers overexpressing IDO or TDO, which dictates a T cell suppressive TME through the establishment of a Treg-macrophage suppressive axis. The gene discussed is AHR; the disease is cancer.